Browse drugs

…ons (DDIs) (p=0.657) and contraindicated DDIs (p=0.670) between simnotrelvir-ritonavir and nirmatrelvir-ritonavir. The most common contraindicated co-…

…vastatin/rosuvastatin) statins; (2A) P-glycoprotein inhibitors (simvastatin/atorvastatin) versus non-inhibitors (pravastatin) in patients p…

… DP1, has recently been proposed to play pro-tumoral functions. OKN4395 is a novel small molecule, highly selective and potent against …

…n and cytolytic activity of PBMCs against SNU-503 and NCI-H508. Ficerafusp alfa showed prolonged and significantly improved tumor cytotoxicity …

…aintenance therapy (MT) consisting of mercaptopurine (6-MP) and methotrexate (MTX). Evidence suggests promising clinical outcomes from the u…

…Ref Funder ID: 10.13039/100004755), which provides avelumab and tuvusertib.Trial Registration NCT05947500References Vendetti FP, Karukonda…

…ion and potential as a therapeutic focus.Methods The potency of AVA-NP-695, a small-molecule ENPP1 inhibitor, was validated through enzyma…

…ed to a 4-fold reduction with the single GLP-1 receptor agonist semaglutide. Remarkably, the anti-tumor effects of RETA persisted after tre…

…activity compared to vehicle, WTX-124 alone or a single dose of WTX-330. Multiplex immunofluorescence analysis of tumors revealed that …

…nts who received more lines of systemic therapy (p=0.08). Serum GDF-15 levels correlated with higher IFN-γ (β = 0.49, p = 0.011), IL-1…

… cells and enhancing antigen presentation via cDC1s (figure 1). Chemerin expression enhances the efficacy of immune checkpoint blockade …

…ence of allergy diagnosis (52.5% vs 53.6%). Patients prescribed msBDP/FF/G were older than those prescribed hsICS/LABA (mean±standard devi…